Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
E-pub ahead of print

Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{1448f31b9d4e4e6fbe483897ea3a3a88,
title = "Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery",
keywords = "Alectinib hepatotoxicity, ALK, CNS efficacy of brigatinib, CNS relapse, Dose-escalated brigatinib",
author = "Urbanska, {Edyta Maria} and Eric Santoni-Rugiu and Melchior, {Linea Cecilie} and Carlsen, {Jonathan Frederik} and S{\o}rensen, {Jens Benn}",
year = "2021",
doi = "10.1016/j.cllc.2020.04.012",
language = "English",
journal = "Clinical Lung Cancer",
issn = "1525-7304",
publisher = "Elsevier Inc",

}

RIS

TY - JOUR

T1 - Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery

AU - Urbanska, Edyta Maria

AU - Santoni-Rugiu, Eric

AU - Melchior, Linea Cecilie

AU - Carlsen, Jonathan Frederik

AU - Sørensen, Jens Benn

PY - 2021

Y1 - 2021

KW - Alectinib hepatotoxicity

KW - ALK

KW - CNS efficacy of brigatinib

KW - CNS relapse

KW - Dose-escalated brigatinib

U2 - 10.1016/j.cllc.2020.04.012

DO - 10.1016/j.cllc.2020.04.012

M3 - Journal article

C2 - 32651064

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

SN - 1525-7304

ER -

ID: 61923785